Nebreda: "Our advantage is that p38 inhibitors are now available"

TVE reports on the recent study on colorectal cancer published in Cancer Cell by Angel R. Nebreda, ICREA and IRB researcher, and BBVA Foundation Cancer Research Professor. Broadcasted in various news slots over the weekend, coinciding with the Intenational Colon Cancer Day, the video describes the identification of the protein p38 as a key regulator of colon cancer progression.



Watch this video in TVE


Related news

27 March 2014

Researchers at IRB discover a key regulator of colon cancer